BioCentury | Sep 24, 2015
Company News

Management tracks

...delivery play leon-nanodrugs GmbH (Munich, Germany) named Theron Odlaug CEO. Odlaug was executive chairman at Cedarburg Hauser Pharmaceuticals Inc....
BioCentury | Apr 14, 2014
Company News

Albany Molecular Research, Cedarburg Hauser deal

...including assumption of liabilities (see BioCentury, March 31). Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Cedarburg Hauser Pharmaceuticals Inc....
BioCentury | Mar 31, 2014
Company News

Albany Molecular Research, Cedarburg Hauser deal

...revenue of $246.6 million. Wells Fargo advised Cedarburg. Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Cedarburg Hauser Pharmaceuticals Inc....
BioCentury | Nov 12, 2012
Company News

Cedarburg Hauser management update

Cedarburg Hauser Pharmaceuticals Inc. , Grafton, Wis. Business: Supply/Service, Biomanufacturing Promoted: John Lynch to CSO from director of R&D WIR Staff...
Items per page:
1 - 4 of 4
BioCentury | Sep 24, 2015
Company News

Management tracks

...delivery play leon-nanodrugs GmbH (Munich, Germany) named Theron Odlaug CEO. Odlaug was executive chairman at Cedarburg Hauser Pharmaceuticals Inc....
BioCentury | Apr 14, 2014
Company News

Albany Molecular Research, Cedarburg Hauser deal

...including assumption of liabilities (see BioCentury, March 31). Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Cedarburg Hauser Pharmaceuticals Inc....
BioCentury | Mar 31, 2014
Company News

Albany Molecular Research, Cedarburg Hauser deal

...revenue of $246.6 million. Wells Fargo advised Cedarburg. Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Cedarburg Hauser Pharmaceuticals Inc....
BioCentury | Nov 12, 2012
Company News

Cedarburg Hauser management update

Cedarburg Hauser Pharmaceuticals Inc. , Grafton, Wis. Business: Supply/Service, Biomanufacturing Promoted: John Lynch to CSO from director of R&D WIR Staff...
Items per page:
1 - 4 of 4